- Home
- PLUS vs VERA Comparison
PLUS vs VERA Comparison
Compare PLUS & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUS
- VERA
- Stock Information
- Founded
- PLUS 1990
- VERA 2016
- Country
- PLUS United States
- VERA United States
- Employees
- PLUS N/A
- VERA N/A
- Industry
- PLUS Retail: Computer Software & Peripheral Equipment
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- PLUS Technology
- VERA Health Care
- Exchange
- PLUS Nasdaq
- VERA Nasdaq
- Market Cap
- PLUS 2.6B
- VERA 2.5B
- IPO Year
- PLUS 1996
- VERA 2021
- Fundamental
- Price
- PLUS $96.76
- VERA $42.01
- Analyst Decision
- PLUS Hold
- VERA Strong Buy
- Analyst Count
- PLUS 1
- VERA 9
- Target Price
- PLUS $90.00
- VERA $53.56
- AVG Volume (30 Days)
- PLUS 100.1K
- VERA 683.6K
- Earning Date
- PLUS 11-05-2024
- VERA 11-07-2024
- Dividend Yield
- PLUS N/A
- VERA N/A
- EPS Growth
- PLUS N/A
- VERA N/A
- EPS
- PLUS 4.08
- VERA N/A
- Revenue
- PLUS $2,195,665,000.00
- VERA N/A
- Revenue This Year
- PLUS $5.69
- VERA N/A
- Revenue Next Year
- PLUS $4.68
- VERA N/A
- P/E Ratio
- PLUS $24.00
- VERA N/A
- Revenue Growth
- PLUS 0.56
- VERA N/A
- 52 Week Low
- PLUS $53.54
- VERA $9.68
- 52 Week High
- PLUS $102.99
- VERA $50.78
- Technical
- Relative Strength Index (RSI)
- PLUS 52.65
- VERA 52.57
- Support Level
- PLUS $96.35
- VERA $39.22
- Resistance Level
- PLUS $99.25
- VERA $50.00
- Average True Range (ATR)
- PLUS 2.09
- VERA 2.41
- MACD
- PLUS -0.38
- VERA 0.24
- Stochastic Oscillator
- PLUS 28.23
- VERA 28.53
About PLUS ePlus inc.
ePlus Inc is a holding company. ePlus through its subsidiaries provides information technology solutions. The company's technology solutions enable organizations to optimize their IT environment and supply chain processes. It also provides consulting, professional and managed services, and complete lifecycle management services including flexible financing solutions. ePlus focuses on selling to medium and large enterprises in the United States and to customers in select international markets including the United Kingdom, the European Union, India, Singapore and Israel.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.